Ligand Pharmaceuticals Incorporated (FRA:LGDN)
Germany · Delayed Price · Currency is EUR 167.00
-5.00 (-2.91%)
At close: Dec 1, 2025
Ligand Pharmaceuticals Market Cap
Ligand Pharmaceuticals has a market cap or net worth of €3.33 billion as of December 2, 2025. Its market cap has increased by 55.09% in one year.
Market Cap
3.33B
Enterprise Value
3.15B
Revenue
214.13M
Ranking
n/a
PE Ratio
80.54
Stock Price
€167.00
Market Cap Chart
Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 62.10M to 3.33B, an increase of 5,270.01%. That is a compound annual growth rate of 13.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 3.45B | 76.35% |
| Dec 31, 2024 | 1.96B | 73.58% |
| Dec 29, 2023 | 1.13B | 6.69% |
| Dec 30, 2022 | 1.06B | -53.48% |
| Dec 31, 2021 | 2.27B | 73.60% |
| Dec 31, 2020 | 1.31B | -19.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |